IGFs及其信号通路研究进展

生物技术通报 ›› 2013, Vol. 0 ›› Issue (9): 43-46.

IGFs及其信号通路研究进展

李聪¹, 马凯丽¹, 刘增力², 王志钢¹

1.内蒙古大学生命科学学院，呼和浩特 010021；
2.内蒙古呼和浩特市第六中学，呼和浩特 010021

收稿日期:2013-05-16 修回日期:2013-09-05 出版日期:2013-09-05 发布日期:2013-09-06
作者简介:李聪，女，硕士，研究方向：基因工程；E-mail：272767655@qq.com
基金资助:
国家自然基金项目（31160469），内蒙古自然基金项目（2011MS0521）

Progress of IGFs and Its Signaling Pathway

Li Cong¹,Ma Kaili¹,Liu Zengli²,Wang Zhigang¹

1. College of Life Science，Inner Mongolia University，Hohhot 010021；
2. The Sixth Middle School of Hohhot，Hohhot 010021

Received:2013-05-16 Revised:2013-09-05 Published:2013-09-05 Online:2013-09-06

摘要/Abstract

摘要： 胰岛素样生长因子（insulin-like growth factors，IGFs）是一个多功能的生长因子家族，对细胞的生长、分化和凋亡起着重要的调节作用。概述近年来在IGFs的成分、结构功能、信号通路以及在疾病中的作用等方面的研究进展，以期为细胞生长调控、动物胚胎发育及肿瘤发生等方面的研究提供参考。

李聪, 马凯丽, 刘增力, 王志钢. IGFs及其信号通路研究进展[J]. 生物技术通报, 2013, 0(9): 43-46.

Li Cong, Ma Kaili, Liu Zengli, Wang Zhigang,. Progress of IGFs and Its Signaling Pathway[J]. Biotechnology Bulletin, 2013, 0(9): 43-46.

[1] Salmon WD Jr, Daughaday WH. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro[J]. J Lab Clin Med, 1957, 49（6）：825-836.
[2] Daughaday WH, Hall K, Salmon WD Jr, et al. On the nomenclature of the somatomedins and insulin like growth factors[J]. J Clin Endocrinol Metab, 1987, 65：1075-1076.
[3] 王志钢, 吴应积, 旭日干. mTOR信号通路与细胞生长调控[J]. 生物物理学报, 2007, 23：1-10.
[4] DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting[J]. Nature, 1990, 345：78-80.
[5] Nef S. The role of IGFs and the Sertoli cell in driving ‘maleness’[J].Endocrine Abstracts, 2013, 31 S2.2 DOI：10.1530/endoabs.31.S2.2
[6] Weng CJ, Hsieh YH, Tsai CM, et al. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma[J]. Ann Surg Oncol, 2010, 17：1808-1815.
[7] Salminen A, Kaarniranta K. Insulin/IGF-I paradox of aging：regulation via AKT/IKK/NF-kappaB signaling[J]. Cell Signal, 2010, 22：573-577.
[8] Cortes-Sempere M, de Miguel MP, Pernia O, et al. IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer[J]. Oncogene, 2013, 32：1274-1283.
[9] Jernberg-Wiklund H, Nilsson K. Targeting the IGF-1R signaling and mechanisms for epigenetic gene silencing in human multiple myeloma[J]. Ups J Med Sci, 2012, 117：166-177.
[10] Davison Z, de Blacquiere GE, Westley BR, et al. Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells：implications for therapy[J]. Neoplasia, 2011, 13：504-515.
[11] Chen RY, Chen HX, Lin JX, et al. In-vivo transfection of pcDNA3.1-IGFBP7 inhibits melanoma growth in mice through apoptosis induc-tion and VEGF downexpression[J]. J Exp Clin Cancer Res, 2010, 29：13.
[12] McMahon M, Ayllón V, Panov KI, et al. Ribosomal 18 S RNA processing by the IGF-I-responsive WDR3 protein is integrated with p53 function in cancer cell proliferation[J]. J Biol Chem, 2010, 285：18309-18318.
[13] Worster DT, Schmelzle T, Solimini NL, et al. Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57^{Kip2[J]. Sci Signal, 2012, 5：ra19.
[14] Borowiec AS, Hague F, Gouilleux-Gruart V, et al. Regulation of IGF-1-dependent cyclin D1 and E expression by hEag1 channels in MCF-7 cells：the critical role of hEag1 channels in G1 phase progression[J]. Biochim Biophys Acta, 2011, 1813：723-730.
[15] Wang Y, Zhu Y, Zhang L, et al. Insulin promotes proliferation, survival, and invasion in endometrial carcinoma by activating the MEK/ERK pathway[J]. Cancer Lett, 2012, 322：223-231.
[16] Leksa V, Pfisterer K, Ondrovicova G, et al. Dissecting mannose 6-phosphate-insulin-like growth factor 2 receptor complexes that control activation and uptake of plasminogen in cells[J]. J Biol Chemi, 2012, 287：22450-22462.
[17] Ma N, Li F, Li D, et al. Igf2-derived intronic miR-483 promotes mouse hepatocellular carcinoma cell proliferation[J]. Mol Cell Biochem, 2012, 361：337-343.
[18] Kim WY, Kim MJ, Moon H, et al. Differential impacts of insulin-like growth factor-binding protein-3（IGFBP-3）in epithelial IGF-induced lung cancer development[J]. Endocrinology, 2011, 152：2164-2173.
[19] Kim HS, Lee WJ, Lee SW, et al. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells[J]. Horm Metab Res, 2010, 42：165-172.
[20] 满孝蕊, 胡绍燕, 吴水燕,等. IGFBP7基因表达下调对急性髓系白血病细胞的影响[J]. 中华血液学杂志, 2012, 33（4）：307-310.
[21] Chen D, Yoo BK, Santhekadur PK, et al. Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma[J]. Clin Cancer Res, 2011, 17：6693-6701.
[22] Benatar T, Yang W, Amemiya Y, et al. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways[J]. Breast Cancer Res Treat, 2012, 133：563-573.}